EntreMed, Inc. · Rockville, MD United States (NASDAQ: ENMD)
| 9640 Medical Center Dr. | Phone: 240-864-2600 |
| Rockville, MD | Fax: 240-864-2601 |
| 20850 | |
| United States | 
Map This Company |
EntreMed, Inc. Rankings
More Companies in Rockville, Maryland
More Companies in These Related Industries: Biologics MfgCompany Description
EntreMed wants to get in between cancer and the blood vessels that feed it. The biotech pharmaceutical company develops drugs that inhibit angiogenesis, or the growth of new blood vessels. Its lead candidate, ENMD-2076, inhibits aurora kinases which regulate cell division and are linked to several cancers. The company has several other product candidates in its pipeline. EntreMed receives royalties from sales of Thalomid, a multiple myeloma therapy marketed by EntreMed's minority shareholder,
To read the full description: Subscribe Now
EntreMed, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ENMD Single Location |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 8 |
Executives
11 executives listed for EntreMed, Inc.'s Rockville, MD location.
| Chairman | Michael Tarnow | |
|---|---|---|
| COO, General Counsel, and Secretary | Cynthia Hu | |
| VP Finance | Sara Capitelli |